Cardiac Phenotype and Gene Mutations in RASopathies

Area of Science:

• Genetics and Molecular Biology
• Cardiology
• Developmental Biology

Background:

• RASopathies are genetic disorders linked to the RAS/MAPK pathway.
• Cardiac anomalies are a primary manifestation in RASopathies, especially Noonan syndrome (NS).
• Noonan syndrome presents diverse cardiac issues, including congenital heart disease (CHD) and hypertrophic cardiomyopathy (HCM).

Purpose of the Study:

• To elucidate molecular mechanisms of cardiac disease in Noonan syndrome.
• To detail clinical and morphological features of pulmonary valve stenosis (PVS) and HCM in NS.
• To correlate genotypes with cardiac phenotypes for improved prognosis and treatment strategies.

Main Methods:

• Literature review focusing on RASopathies and cardiac manifestations.
• Analysis of genotype-cardiac phenotype correlations in Noonan syndrome.
• Review of current and emerging therapeutic strategies, including targeted therapies.

Main Results:

• Germline mutations in RAS/MAPK pathway genes drive cardiac pathologies in NS.
• Pulmonary valve stenosis (PVS) and hypertrophic cardiomyopathy (HCM) are the most prevalent cardiac disorders in NS.
• Genotype-specific patterns influence cardiac disease severity and long-term outcomes.

Conclusions:

• Understanding genotype-phenotype correlations is crucial for predicting cardiac disease progression in NS.
• Targeted therapies inhibiting the RAS/MAPK pathway show promise for treating cardiac conditions like HCM.
• Further research into molecular mechanisms can guide personalized treatment approaches for RASopathies.